Skip to content
Screener

X4 Pharmaceuticals XFOR Q3 2025 earnings

Reported November 5, 2025 · Before market open

Revenue$1.8MBeat by $32.0K
EPS-$0.69Beat by $0.10
Revenue estimate$1.7M
EPS estimate-$0.79

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$2.3M
EPS estimate-$0.19

FAQ

When did X4 Pharmaceuticals report Q3 2025 earnings?
X4 Pharmaceuticals (XFOR) reported Q3 2025 earnings on November 5, 2025 before market open.
What were X4 Pharmaceuticals's Q3 2025 revenue and EPS?
X4 Pharmaceuticals reported revenue of $1.8M and eps of $-0.69 for Q3 2025.
Did X4 Pharmaceuticals beat estimates in Q3 2025?
Revenue beat the consensus estimate of $1.7M by $32.0K. EPS beat the consensus estimate of $-0.79 by $0.10.
How did X4 Pharmaceuticals's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 215.2% from $560.0K a year earlier and eps declined 283.3% from $-0.18.
Where can I find X4 Pharmaceuticals's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001501697-25-000041) and the 10-Q periodic report (0001501697-25-000043) directly on SEC EDGAR. The filing index links above go to sec.gov.